Currently, Vir Biotechnology Inc’s (VIR) stock is trading at $5.7, marking a fall of -2.48% from last night’s close. At this price, the stock is -58.48% below its 52-week high of $13.74 and 37.30% above its 52-week low of $4.16.
As well, it is important to consider VIR stock ratios such as price-to-sales, which is currently 47.88.VIR’s price to book ratio for the most recent quarter was 1.00, resulting in an 1.59 price to cash per share for the period.
How does Vir Biotechnology Inc (VIR) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Vir Biotechnology Inc (VIR): Earnings History
If we examine Vir Biotechnology Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$1.17, beating the consensus of -$0.86. In other words, it beat the consensus by -$0.31, resulting in a -35.98% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$1.17 in contrast with the Outlook of -$0.86. That was a difference of -$0.31 and a surprise of -35.98%.
Vir Biotechnology Inc (NASDAQ: VIR) Ownership Details
I will give a breakdown of the key shareholders in Vir Biotechnology Inc (VIR). Recent figures show that the company’s insiders hold 10.42% of shares. A total of 316 institutional investors hold shares in the company, making 78.24% of its stock and 87.33% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is SB Investment Advisers (UK) LTD holding total of 16.68 shares that make 11.99% of the company’s total number of shares and are currently priced at 95.43 million.
The securities firm Blackrock Inc. holds 15.97 shares of VIR, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 11.48%, and the holding percentage of shares is valued at 91.33 million.
